Focal Medical, Inc. specializes in advanced medical technologies aimed at improving patient outcomes through innovative solutions. The company focuses on developing minimally invasive procedures that leverage cutting-edge imaging and therapeutic techniques. Their products are designed to enhance precision in medical interventions, thereby reducing recovery times and improving overall patient safety. Focal Medical emphasizes the integration of real-time imaging technologies, which allow healthcare professionals to visualize and target specific areas of interest during procedures, leading to more effective treatments.

In addition to imaging technologies, Focal Medical is committed to advancing therapeutic modalities that complement their diagnostic tools. Their approach includes the use of novel materials and devices that facilitate targeted delivery of treatments, ensuring that therapies are administered with high accuracy. The company’s dedication to research and development is evident in their ongoing efforts to refine these technologies, aiming to set new standards in the medical field and provide healthcare providers with the tools necessary to deliver superior care.

United States

Focal Medical, Inc. is a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system. The Company's lead product is a targeted therapeutic product delivering gemcitabine (an FDA approved chemotherapeutic) actively and directly to the pancreas by non-circulatory pathways to treat pancreatic cancer.

111 James Jackson Ave, Suite 131, Cary, North Carolina 27513, US

Focal Medical, Inc.

Company Details